CPH 0.00% 0.9¢ creso pharma limited

The bashers are focusing on costs because a healthy increase in...

  1. 453 Posts.
    lightbulb Created with Sketch. 213
    The bashers are focusing on costs because a healthy increase in revenue doesn't suit their narrative.

    As I pointed out, with some calculated analysis, after the last Quarterly Report - large corporate costs were down 45% from the previous quarter, cost savings on manufacturing & operations down 7.5% and staff costs constant. In business, staff costs grow in line with company expansion - so make a note of that experts ............. keep up eddie.

    As a comparison, I heard a podcast yesterday that looked at the Top 5 small caps of 2021. Their costs went like this ;
    Sayona - SP up 1447% - CY Loss $4.38 million
    Red Hill Iron - SP up 1189% - CY Loss $2.65 million
    Provence Resources - SP up 971% - CY Loss $14.5 million
    Arizona Lithium - SP up 933% - CY Loss $2.9million
    Lake Resources - SP up 887% - CY Loss $3.46 million

    Reigning in costs and increasing revenue is what it's all about for a start-up to be successful. The fundamentals of Creso are still good - except for .......... (I'll address that later for you Sadaji)
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.